167 related articles for article (PubMed ID: 10223580)
1. A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer.
Toljanic JA; Bedard JF; Larson RA; Fox JP
Cancer; 1999 Apr; 85(8):1843-8. PubMed ID: 10223580
[TBL] [Abstract][Full Text] [Related]
2. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation.
Yamagata K; Onizawa K; Yanagawa T; Hasegawa Y; Kojima H; Nagasawa T; Yoshida H
Bone Marrow Transplant; 2006 Aug; 38(3):237-42. PubMed ID: 16850033
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment strategies for infection prevention in chemotherapy patients.
Peterson DE
NCI Monogr; 1990; (9):61-71. PubMed ID: 2111469
[TBL] [Abstract][Full Text] [Related]
4. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy.
Vekemans M; Robinson J; Georgala A; Heymans C; Muanza F; Paesmans M; Klastersky J; Barette M; Meuleman N; Huet F; Calandra T; Costantini S; Ferrant A; Mathissen F; Axelsen M; Marchetti O; Aoun M
Clin Infect Dis; 2007 Jun; 44(12):1593-601. PubMed ID: 17516403
[TBL] [Abstract][Full Text] [Related]
5. Dental assessment prior to stem cell transplant: treatment need and barriers to care.
Durey K; Patterson H; Gordon K
Br Dent J; 2009 May; 206(9):E19; discussion 478-9. PubMed ID: 19360024
[TBL] [Abstract][Full Text] [Related]
6. A survey of clinicians: prioritization of dental treatment in leukemia patients prior to chemotherapy.
Wong F; Toljanic JA
Int J Prosthodont; 2009; 22(3):303-6. PubMed ID: 19548416
[TBL] [Abstract][Full Text] [Related]
7. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
[TBL] [Abstract][Full Text] [Related]
8. Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome.
Raut A; Huryn JM; Hwang FR; Zlotolow IM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jul; 92(1):49-55. PubMed ID: 11458245
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of dental and periodontal status in a group of oncological patients before chemotherapy.
López-Galindo MP; Bagán JV; Jiménez-Soriano Y; Alpiste F; Camps C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E17-21. PubMed ID: 16388287
[TBL] [Abstract][Full Text] [Related]
10. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
[TBL] [Abstract][Full Text] [Related]
11. Need for dental treatment following cardiac valve surgery: a clinical study.
Deppe H; Auer-Bahrs J; Kolk A; Hall D; Wagenpfeil S
J Craniomaxillofac Surg; 2007; 35(6-7):293-301. PubMed ID: 17761432
[TBL] [Abstract][Full Text] [Related]
12. Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study.
Napeñas JJ; Brennan MT; Coleman S; Kent ML; Noll J; Frenette G; Nussbaum ML; Mougeot JL; Paster BJ; Lockhart PB; Bahrani-Mougeot FK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):554-60. PubMed ID: 20303053
[TBL] [Abstract][Full Text] [Related]
13. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
Hartmann JT; von Vangerow A; Fels LM; Knop S; Stolte H; Kanz L; Bokemeyer C
Br J Cancer; 2001 Feb; 84(3):313-20. PubMed ID: 11161394
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
18. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
19. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
Caggiano V; Weiss RV; Rickert TS; Linde-Zwirble WT
Cancer; 2005 May; 103(9):1916-24. PubMed ID: 15751024
[TBL] [Abstract][Full Text] [Related]
20. Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
Cervantes F; Sureda A; Hernández-Boluda JC; Martino R; Brunet S; Borrego D; Antich JL; Montserrat E
Haematologica; 2001 Dec; 86(12):1281-6. PubMed ID: 11726320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
